This article tells how anti-aging startups are getting attention from investors:
It turns out that Insilico is just down the street from where I work, on one of the Johns Hopkins campuses. So I checked out their web site. They have a biological age calculator. You plug in your blood work numbers and it calculates your estimated age.
The primary game plan at Juvenescence, explains Bailey, is to come up with various operations engaged in developing new anti-aging drugs. Juvenescence AI is a joint venture they’ve just set up with Alex Zhavoronkov, who runs Insilico Medicine, based in Baltimore. Mellon met Zhavoronkov while he was researching his book, says Bailey, and believes that the tech the scientist developed can illuminate new programs with a better chance of success.
“They are going to take up to 5 molecules from us every year for development,” says Zhavoronkov, an enthusiastic advocate of AI in drug research who’s also been working on some alliances with Big Pharma players. The group has invested about $7 million in the technology so far, he says, getting the JV set up. More will follow.
It turns out that Insilico is just down the street from where I work, on one of the Johns Hopkins campuses. So I checked out their web site. They have a biological age calculator. You plug in your blood work numbers and it calculates your estimated age.